FindTrial
Sign In

A prospective, randomized controlled clinical trial of use indocyanine green fluorescence image-guided laparoscopic common bile duct exploration

A prospective, randomized controlled clinical trial of use indocyanine green fluorescence image-guided laparoscopic common bile duct exploration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063971
Enrollment
Unknown
Registered
2022-09-22
Start date
2022-09-22
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct stone

Interventions

experimental group:Injected indocyanine green 5mgintravenously 0.5 hours before operation
control group:Routine operation

Sponsors

Department of General Surgery, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Color ultrasound, CT, MRI can be used to diagnose choledocholithiasis or intrahepatic choledocholithiasis; 2. Child-Pugh score of liver function grade A; 3. ASA grade 1-4; 4. Agree to participate in this experiment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to ICG preparations or iodine. 2. Abnormal liver function. 3. Complicated liver lesions require liver resection. 4. Preoperative consideration of patients with malignant lesions. 5. Patients with other organ dysfunction.

Design outcomes

Primary

MeasureTime frame
time of opening common bile duct;—

Secondary

MeasureTime frame
operation time;suture time;surgical complications;number of stones;postoperative hospitalization days;—

Countries

China

Contacts

Public ContactJia Qianbin

Department of General Surgery, West China Hospital, Sichuan University

qb_jia@msn.com+86 18980601464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026